News Alert

HHS to Issue Guidance on 340B Rebates, IRA Interaction Within 30 Days

HHS plans to release stakeholder guidance on 340B rebates in 30 days.
The U.S. Department of Health and Human Services (HHS) plans to release guidance within 30 days on 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Trump’s FY 2026 Budget Blueprint Includes $33 Billion in HHS Cuts, No Details on 340B Plans

The White House’s Discretionary Budget Request released Friday proposes nearly $94 billion in base discretionary HHS funding—a $33.3 billion cut.
President Donald Trump’s Fiscal Year 2026 budget blueprint released Friday calls for major cuts and shakeups at the U.S. Department [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

National HIV Group Voices Concerns Over Sen. Cassidy’s 340B Probe Findings, Reform Recommendations 

Ryan White Clinics for 340B Access detailed its concerns with the legislative solutions Senate HELP Committee Chairman Bill Cassidy (R-La.) proposed in a recent report on the 340B program. 
A major national 340B provider advocacy group this week cautioned that proposed 340B reforms stemming from a high-profile GOP U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court Backs HHS in Dispute Over DSH Calculation, 340B Providers Condemn Decision Which Could Impact Eligibility for Some Hospitals

The Supreme Court sided with federal health officials this week in a dispute over the Disproportionate Share Hospital (DSH) formula.
The U.S. Supreme Court on Tuesday sided against more than 200 hospitals in a dispute over Medicare disproportionate share hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Federal Judge Grills Both Sides in Key Hearing on 340B Rebate Dispute

A hearing on five drug industry 340B rebate lawsuits took place April 29 in the U.S. District Court for the District of Columbia.
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Holds High-Stakes Hearings Today on Five Drug Industry 340B Rebate Lawsuits

U.S. District Judge Dabney Friedrich of the District of Columbia is presiding over five April 29 hearings over drugmaker 340B rebate lawsuits. She previously largely sided with Novartis and United Therapeutics in a separate case on drugmaker contract pharmacy restrictions.
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audits Find Two Drugmakers Overcharged for 340B Drugs, Driving Calls for More Drug Industry Oversight 

HRSA released the results of its first two drugmaker audits of 2025 this month.
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former 340B Health, Evernorth Executives Join Walgreens 

Greg Doggett and Ben Olson, two long-time executives in the 340B world, have recently taken on key positions at retail pharmacy giant Walgreens.
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live